E-Z-EM Launches www.RSDecon.com Site for RSDL

Business Wire, April 27, 2006

LAKE SUCCESS, N.Y. -- E-Z-EM, Inc. (NASDAQ:EZEM) today announced the launch of www.RSDecon.com, a new website dedicated to the Company's Reactive Skin Decontamination Lotion (RSDL(TM)) product. The Company developed the site to provide an informative resource for the military and emergency first responder personnel who make up the two primary markets for the product.

RSDL is a patented, broad-spectrum, skin decontamination product intended to remove or neutralize chemical warfare (CW) agents or T2 toxin from the skin. Originally developed for the Canadian Ministry of Defense, RSDL has since been adopted by several military services around the world, and is currently undergoing final configuration testing by the U.S. Department of Defense (DoD) for eventual deployment with U.S. troops. The U.S. Department of Defense authorized the sale of RSDL to first responder organizations in September of 2004. The U.S. Food and Drug Administration (FDA) issued 510(k) clearance for RSDL in March of 2003.

Commenting on the announcement, Anthony A. Lombardo, President and CEO of E-Z-EM, said, "RSDL is a very high profile product, so we developed this dedicated resource with the particular needs of military and first responder markets in mind. This space is intended to be dynamic, and will grow and expand over time as all good websites should. We worked closely with our contacts at the DoD while this site was developed, and appreciate their assistance in getting the site launched."

About E-Z-EM, Inc.

E-Z-EM is a publicly traded healthcare company founded in 1962, and has established itself as one of the most recognized brands in diagnostic imaging of the GI tract. From the first barium contrast systems introduced over 40 years ago, to today's advanced products for CT imaging and virtual colonoscopy, E-Z-EM has continually developed innovative imaging and diagnostic solutions for physicians treating GI diseases. E-Z-EM is also a respected contract manufacturer of specialized liquid products, and has been the exclusive global manufacturer of RSDL(TM) since 1996. In April of 2005, E-Z-EM completed the acquisition of all assets associated with RSDL, and now is the product's exclusive worldwide marketer.

The statements made in this document contain certain forward-looking statements. Words such as "expects," "intends," "anticipates," "plans," "believes," "seeks," "estimates" or variations of such words and similar expressions, are intended to identify such forward-looking statements. The forward-looking statements contained in this release may involve numerous risks and uncertainties, known and unknown, beyond the Company's control. Such risks and uncertainties include: the ability of the Company to develop its products, successful completion of DoD field testing by the U.S. government and placement of DoD order for RSDL, the impact on future sales of the RSDecon website, future orders of RSDL by first responder organizations, general military and first-responder market acceptance and sales of RSDL, market acceptance and sales of VoLumen(R); future actions by the FDA or other regulatory agencies, overall economic conditions, general market conditions, price increases of raw materials and components, foreign currency exchange rate fluctuations as well as the risk factors listed from time to time in the SEC filings of E-Z-EM, Inc., including but not limited to its Annual Report on its Form 10-Q for the quarter ended March 4, 2006 and its Form 10-K for the fiscal year ended May 28, 2005. Consequently, actual future results may differ materially from the anticipated results expressed in the forward-looking statements, and investors are cautioned not to place undue reliance on the forward-looking statements included in this release.